In particular, in stage 2 CKD, its growth is associated with an increase in cystatin C levels and a decrease in glomerular filtration rate and probably the progression of obesity, while in stage 1, such a relationship is not yet formed. The gene discussed is CST3; the disease is obesity disorder.